Wiener Privatklinik
| トルコ | オーストリア | スペイン | |
| 骨髄移植術 | から $36,000 | から $140,000 | から $71,782 |
| 非血縁者間同種骨髄移植術 | から $80,000 | から $180,000 | から $150,000 |
| 血漿交換術 | から $1,200 | から $2,000 | から $1,800 |
| 白血病化学療法 | から $8,000 | から $15,000 | から $20,000 |
| 生物学的療法 | から $5,500 | から $20,000 | から $15,000 |
Bookimedは血液腫瘍科治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。血液腫瘍科治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。血液腫瘍科治療の旅路でお一人になることはありません。
Univ.-Prof. Dr. Wolfgang Johannes Köstler is a board-certified specialist for Internal Medicine, Hematology/Oncology, and Intensive Care Medicine who specializes in hematology & internal oncology, intensive care medicine. He is one of the top-rated breast cancer and sarcoma oncologist specialists and has extensive experience in the field and has received degrees from the Medical University of Vienna and the Weizmann Institute of Science. He has also had special training at Memorial Sloan-Kettering Cancer Center and Royal Prince Alfred Hospital.
Professor Drach is a specialist in oncology with a PhD from the Medical University of Vienna. He has experience in research, internal medicine, hematologic oncology, nutrition, and lifestyle in cancer. He is the Director of the Josefstadt Private Clinic in Vienna and a member of the Board of Directors of the Austrian Society of Hematology and Oncology. He has published more than 120 scientific papers and given more than 200 lectures/presentations.
Univ.-Prof. Dr. Heinz Gisslinger is a leading hematologist and internal oncologist at the Medical University of Vienna and the Confraternität Private Clinic Josefstadt. He helped found the Laboratory for Myeloproliferative Neoplasms. He is Program Director for Myeloproliferative Neoplasms and leads clinical and translational research.
He pioneered interferon therapy for myeloproliferative neoplasms (MPNs). He first used it clinically in the 1980s and has advanced it for more than four decades. His expertise includes polycythemia vera, essential thrombocythemia, primary myelofibrosis, chronic myeloid leukemia, and multiple myeloma.